BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15136887)

  • 1. Efficacy of covered metallic stents in the treatment of unresectable malignant biliary obstruction.
    Miyayama S; Matsui O; Akakura Y; Yamamoto T; Nishida H; Yoneda K; Kawai K; Toya D; Tanaka N; Mitsui T; Asada Y
    Cardiovasc Intervent Radiol; 2004; 27(4):349-54. PubMed ID: 15136887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous biliary covered stent insertion in patients with malignant duodenobiliary obstruction.
    Lee E; Gwon DI; Ko GY; Sung KB; Yoon HK; Shin JH; Kim JH; Ko HK; Song HY
    Acta Radiol; 2015 Feb; 56(2):166-73. PubMed ID: 24518689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallic stents in malignant biliary obstruction: prospective long-term clinical results.
    Lee BH; Choe DH; Lee JH; Kim KH; Chin SY
    AJR Am J Roentgenol; 1997 Mar; 168(3):741-5. PubMed ID: 9057527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic management of malignant biliary obstruction by means of covered metallic stents: primary stent placement vs. re-intervention.
    Kida M; Miyazawa S; Iwai T; Ikeda H; Takezawa M; Kikuchi H; Watanabe M; Imaizumi H; Koizumi W
    Endoscopy; 2011 Dec; 43(12):1039-44. PubMed ID: 21971926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial.
    Kitano M; Yamashita Y; Tanaka K; Konishi H; Yazumi S; Nakai Y; Nishiyama O; Uehara H; Mitoro A; Sanuki T; Takaoka M; Koshitani T; Arisaka Y; Shiba M; Hoki N; Sato H; Sasaki Y; Sato M; Hasegawa K; Kawabata H; Okabe Y; Mukai H
    Am J Gastroenterol; 2013 Nov; 108(11):1713-22. PubMed ID: 24042190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study.
    Kullman E; Frozanpor F; Söderlund C; Linder S; Sandström P; Lindhoff-Larsson A; Toth E; Lindell G; Jonas E; Freedman J; Ljungman M; Rudberg C; Ohlin B; Zacharias R; Leijonmarck CE; Teder K; Ringman A; Persson G; Gözen M; Eriksson O
    Gastrointest Endosc; 2010 Nov; 72(5):915-23. PubMed ID: 21034892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partially covered metal stents have longer patency than uncovered and fully covered metal stents in the management of distal malignant biliary obstruction: a retrospective study.
    Yokota Y; Fukasawa M; Takano S; Kadokura M; Shindo H; Takahashi E; Hirose S; Kawakami S; Fukasawa Y; Sato T; Enomoto N
    BMC Gastroenterol; 2017 Oct; 17(1):105. PubMed ID: 29020933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covered Wallstents for palliation of malignant biliary obstruction: primary stent placement versus reintervention.
    Ornellas LC; Stefanidis G; Chuttani R; Gelrud A; Kelleher TB; Pleskow DK
    Gastrointest Endosc; 2009 Oct; 70(4):676-83. PubMed ID: 19560137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for covered metallic stent migration in patients with distal malignant biliary obstruction due to pancreatic cancer.
    Nakai Y; Isayama H; Kogure H; Hamada T; Togawa O; Ito Y; Matsubara S; Arizumi T; Yagioka H; Mizuno S; Sasaki T; Yamamoto N; Hirano K; Tada M; Koike K
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1744-9. PubMed ID: 24720610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction.
    Saleem A; Leggett CL; Murad MH; Baron TH
    Gastrointest Endosc; 2011 Aug; 74(2):321-327.e1-3. PubMed ID: 21683354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction.
    Nakai Y; Isayama H; Komatsu Y; Tsujino T; Toda N; Sasahira N; Yamamoto N; Hirano K; Tada M; Yoshida H; Kawabe T; Omata M
    Gastrointest Endosc; 2005 Nov; 62(5):742-8. PubMed ID: 16246690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of metallic stent for unresectable distal malignant biliary obstruction in elderly patients.
    Sakai Y; Iwai T; Shimura K; Gon K; Koizumi K; Ijima M; Chiba K; Nakatani S; Sugiyama H; Tsuyuguchi T; Kamisawa T; Maetani I; Kida M
    World J Gastroenterol; 2018 Jan; 24(1):69-75. PubMed ID: 29358883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term retrospective analysis of metallic stents in malignant biliary obstruction].
    Cao G; Yang Rj
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):121-4. PubMed ID: 18458682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized study comparing double layer and Tannenbaum stents in distal malignant biliary stenosis.
    Katsinelos P; Paroutoglou G; Chatzimavroudis G; Terzoudis S; Zavos C; Gelas G; Pilpilidis I; Kountouras J
    Acta Gastroenterol Belg; 2010; 73(4):445-50. PubMed ID: 21299153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous placement of metallic stents in the management of malignant biliary obstruction.
    Chiou YY; Tseng HS; Chiang JH; Hwang JI; Chou YH; Chang CY
    J Formos Med Assoc; 2005 Oct; 104(10):738-43. PubMed ID: 16385376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial.
    Mukai T; Yasuda I; Nakashima M; Doi S; Iwashita T; Iwata K; Kato T; Tomita E; Moriwaki H
    J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):214-22. PubMed ID: 22415652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curved planar reformatted images of MDCT for differentiation of biliary stent occlusion in patients with malignant biliary obstruction.
    Bang BW; Jeong S; Lee DH; Kim CH; Cho SG; Jeon YS
    AJR Am J Roentgenol; 2010 Jun; 194(6):1509-14. PubMed ID: 20489090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folfirinox chemotherapy prolongs stent patency in patients with malignant biliary obstruction due to unresectable pancreatic cancer.
    Kang J; Lee SH; Choi JH; Paik WH; Ahn DW; Jeong JB; Ryu JK; Kim YT
    Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):590-595. PubMed ID: 32532598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of covered metallic stents in malignant biliary stenosis--prominent effectiveness in gallbladder carcinoma.
    Kawamoto H; Ishida E; Okamoto Y; Okada H; Sakaguchi K; Nakagawa M; Sugihara T; Shiratori Y
    Hepatogastroenterology; 2005; 52(65):1351-6. PubMed ID: 16201072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallic stents in malignant biliary obstruction: results of a multicenter European study of 240 patients.
    Rossi P; Bezzi M; Rossi M; Adam A; Chetty N; Roddie ME; Iacari V; Cwikiel W; Zollikofer CL; Antonucci F
    J Vasc Interv Radiol; 1994; 5(2):279-85. PubMed ID: 7514463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.